First Time Loading...

TherapeuticsMD Inc
NASDAQ:TXMD

Watchlist Manager
TherapeuticsMD Inc Logo
TherapeuticsMD Inc
NASDAQ:TXMD
Watchlist
Price: 1.96 USD Market Closed
Updated: May 8, 2024
Section:
 

Wall Street
Price Targets

TXMD Price Targets Summary
TherapeuticsMD Inc

Wall Street analysts forecast TXMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TXMD is 5 USD .

TXMD Lowest Forecast
Wall Street Target
Not Available
TXMD Average Forecast
Wall Street Target
5 USD
155% Upside
TXMD Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
5 USD
155% Upside
Highest
Price Target
Not Available
TherapeuticsMD Inc Competitors:
Price Targets
600195
China Animal Husbandry Industry Co Ltd
35% Upside
H02
Haw Par Corporation Ltd
75% Upside
688356
Jenkem Technology Co Ltd
33% Upside
002317
Guangdong Zhongsheng Pharmaceutical Co Ltd
51% Downside
600195
China Animal Husbandry Industry Co Ltd
35% Upside
H02
Haw Par Corporation Ltd
75% Upside
688356
Jenkem Technology Co Ltd
33% Upside
002317
Guangdong Zhongsheng Pharmaceutical Co Ltd
51% Downside
APLLTD
Alembic Pharmaceuticals Ltd
13% Downside
H
000908
Hunan Jingfeng Pharmaceutical Co Ltd
662% Upside
G
GLENMARK
Glenmark Pharmaceuticals Ltd
10% Downside
4536
Santen Pharmaceutical Co Ltd
15% Upside

Revenue
Forecast

Revenue Estimate
TherapeuticsMD Inc

For the last 8 years the compound annual growth rate for TherapeuticsMD Inc's revenue is -29%. The projected CAGR for the next 2 years is 167%.

-29%
Past Growth
167%
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
TherapeuticsMD Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
TherapeuticsMD Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-58%
Average Miss
What are analyst estimates?

See Also

Summary
TXMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
TXMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TXMD stock valuation using valuation multiples.
Wall Street Estimates
TXMD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TXMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TXMD's stock price target?
Price Target
5 USD

According to Wall Street analysts, the average 1-year price target for TXMD is 5 USD .

What is TherapeuticsMD Inc's Revenue forecast?
Projected CAGR
167%

For the last 8 years the compound annual growth rate for TherapeuticsMD Inc's revenue is -29%. The projected CAGR for the next 2 years is 167%.

ALPHA SPREAD
Join more than 135,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.